Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Bone Marrow Transplantation

  Free Subscription


Articles published in Blood

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    June 2024

  1. Haploidentical bone marrow transplant for SCD.
    Blood. 2024;143:2677.
    PubMed    


    March 2024
  2. KASSIM AA, de la Fuente J, Nur E, Wilkerson K, et al
    An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
    Blood. 2024 Mar 17:blood.2023023301. doi: 10.1182/blood.2023023301.
    PubMed     Abstract available


  3. BENZ EJ JR, Silberstein LE, Panepinto J
    "Treatment with curative intent": the emergence of genetic therapies for sickle cell anemia.
    Blood. 2024;143:967-970.
    PubMed     Abstract available


    April 2023
  4. DEZERN A, Zahurak ML, Symons HJ, Cooke KR, et al
    Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
    Blood. 2023 Apr 21:blood.2023020435. doi: 10.1182/blood.2023020435.
    PubMed     Abstract available


  5. LEDERER K, Maillard I
    New mechanisms of GVHD suppression by Tregs.
    Blood. 2023;141:1655-1657.
    PubMed    


    March 2023
  6. RAMOS TL, Bolivar-Wagers S, Jin S, Thangavelu G, et al
    Prevention of acute GVHD using an orthogonal IL-2/IL-2Rbeta system to selectively expand regulatory T cells in vivo.
    Blood. 2023;141:1337-1352.
    PubMed     Abstract available


    November 2022
  7. COOPER JP, Abkowitz JL
    How we diagnose and treat acute graft-versus-host disease after solid organ transplantation.
    Blood. 2022 Nov 17. pii: 493251. doi: 10.1182/blood.2022015954.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bone Marrow Transplantation is free of charge.